Hostname: page-component-84b7d79bbc-g78kv Total loading time: 0 Render date: 2024-07-30T13:11:33.830Z Has data issue: false hasContentIssue false
  • English
  • Français

Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136 → Ser)

Published online by Cambridge University Press:  09 March 2007

Bernard Vialettes ,
Pascal Reynier ,
Catherine Atlan-Gepner ,
Nadia Mekki ,
Laurence Lesluyes-Mazzochi ,
Gérard Luc ,
Denis Lairon  and
Yves Malthiery
Bernard Vialettes*
Affiliation:
Service de Nutrition, Maladies Métaboliques, Endocrinologie, Hôpital Sainte Marguerite, Université de la Méditerranée UPRES EA 2193, Marseille, France
Pascal Reynier
Affiliation:
Laboratoire de Biochimie, Université d'Angers, Angers, France
Catherine Atlan-Gepner
Affiliation:
Service de Nutrition, Maladies Métaboliques, Endocrinologie, Hôpital Sainte Marguerite, Université de la Méditerranée UPRES EA 2193, Marseille, France
Nadia Mekki
Affiliation:
INSERM U476, Marseille, France
Laurence Lesluyes-Mazzochi
Affiliation:
Service de Nutrition, Maladies Métaboliques, Endocrinologie, Hôpital Sainte Marguerite, Université de la Méditerranée UPRES EA 2193, Marseille, France
Gérard Luc
Affiliation:
Institut Pasteur, Lille, France
Denis Lairon
Affiliation:
INSERM U476, Marseille, France
Yves Malthiery
Affiliation:
Laboratoire de Biochimie, Université d'Angers, Angers, France
*
*Corresponding author: Professor B. Vialettes, fax +33 4 91 74 55 03, email bvialett@mail.ap-hm.fr
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This present case report describes two siblings with severe type V hyperlipoproteinaemia, diagnosed very early in life and due to the combination of the common apolipoprotein (Apo) E2 allele and a rare mutant variant of ApoE, ApoE3 (Arg 136 → Ser). Phenotyping of ApoE falsely identified E2/E2 phenotype. The presence of mutated ApoE was suspected on an unusual restriction polymorphism of a Hha 1 restriction site and confirmed by sequence analysis of the cloned polymerase chain reaction fragment of exon 4 and familial segregation study. The severity of the hypertriacylglycerolaemia was modulated by the lipid content of the diet. A low-fat diet enriched in medium-chain triacylglycerol (TAG) decreased but did not normalize plasma TAG levels in both affected patients of the pedigree. A standardized lipid-enriched test meal showed a marked impairment of TAG-rich lipoprotein (TRL) clearance, especially the exogeneous TRL bearing ApoB-48 which still represented 79 % of total TRL 7 h after the fat load. Finally, differences between the male and female siblings with the existence of a consanguine relationship in their parents suggested the involvement of other genetic factors in modulating the severity of phenotypic expression. This observation reinforces the usefulness of genotyping of ApoE for the characterization of genetic hypertriacylglycerolaemia and selection of the appropriate diet and treatment.

Keywords

Apolipoprotein EHypertriacylglycerolaemiaHyperlipoproteinaemiaTriacylglycerol-rich lipoprotein
Type
Research Article
Information
British Journal of Nutrition , Volume 83 , Issue 6 , June 2000 , pp. 615 - 622
Copyright
Copyright © The Nutrition Society 2000

References

Bard, JMParra, HJDouste-Blazy, P and Fruchart, JC (1990) Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant on lipoprotein particles defined by their apolipoprotein compositions Metabolism 39, 269–273.CrossRefGoogle Scholar
Bjoarkegren, J, Hamsten, AMilne, RW and Karpe, F (1997) Alteration of VLDL composition during alimentary lipemia Journal of Lipid Research 38, 301–314.CrossRefGoogle Scholar
Boerwinkle, EBrown, SRichey Sharett, AHeiss, G and Patsch, W (1994) Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations American Journal of Human Genetics 54, 341–360.Google Scholar
Brenninkmeijer, BJStuyt, PMJDemacker, MStalenhoef, AFH and Van't Laar, A (1987) Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype Journal of Lipid Research 28, 361–370.CrossRefGoogle Scholar
Brown, AJ and Roberts, DCK (1991) The effect of fasting triglyceride and concentration and apolipoprotein E polymorphism on postprandial lipemia Arteriosclerosis Thrombosis 11, 1737–1744.CrossRefGoogle ScholarPubMed
Civeira, FPovoci, MCenarro, A, Vilella, EGonzales, J, Garcia-Otin, AL and Ordovas, JM (1996) Apo E variants in patients with type III hyperlipoproteinemia Atherosclerosis 127, 273–282.CrossRefGoogle ScholarPubMed
Cohn, JSJohnson, EJMillar, HS, Cohn, SDMilne, RW, Marcel, YLRussel, RM and Schaefer, EJ (1993) Contribution of apo B-48 and apo B-100 triglyceride-rich lipoprotein (TRL) to postprandial increases in plasma concentration of TRL triglycerides and retinyl esters Journal of Lipid Research 34, 2033–2039.CrossRefGoogle ScholarPubMed
Das, HKMcPherson, J, Bruns, GAPKarathanasis, SK and Breslow, JL (1985) Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene Journal of Biological Chemistry 260, 6240–6247.CrossRefGoogle ScholarPubMed
Dubois, CArmand, M Azaiss-Baesco V, Portugal, HPauli, AMBernard, PM, Latge, CLafont, H, Borel, P and Lairon, D (1994) Effects of moderate amounts of emulsified dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults American Journal of Clinical Nutrition 60, 374–382.CrossRefGoogle ScholarPubMed
Falko, JMSchonfeld, GWitltum, JLKolar, J and Weidman, SW (1979) Effects of oestrogen therapy on apolipoprotein E in type III hyperlipoproteinemia Metabolism 28, 1171–1177.CrossRefGoogle Scholar
Feussner, GAlbanese, M and Mann, WA (1996) Apolipoprotein E2 (Arg 136→Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinemia European Journal of Clinical Investigation 26, 13–23.CrossRefGoogle Scholar
Ghiselli, GSchaefer, EJGascon, P and Brewer, HB (1981) Type III hyperlipoproteinemia associated with apolipoprotein E deficiency Science 214, 1239–1241.CrossRefGoogle ScholarPubMed
Groot, PHEVan Stiphout, WAHJKrauss, XHJansen, HVan Tol, AVan Ramshorst, EChin-On, S, Hofman, ACresswell, SR and Havekes, L (1991) Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease Arteriosclerosis Thrombosis 11, 653–662.CrossRefGoogle ScholarPubMed
Havekes, Lde Wit, ELeuven, JGKlasen, EUtermann, G, Weber, W and Beisigel, U (1986) Apolipoprotein E3-Leiden: a new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia Human Genetics 73, 157–163.CrossRefGoogle ScholarPubMed
Havel, RJChao, YSWindler, EE, Kotite, L and Guo, LSS (1980) Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia Proceedings of National Academy of Sciences (USA) 77, 4349–4353.CrossRefGoogle ScholarPubMed
Hegele, RALittle, JAVezina, CMaguire, GFTu, LWolever, TSJenkins, DJ and Connelly, PW (1993) Hepatic lipase deficiency. Clinical, biochemical and molecular genetic characteristics Arteriosclerosis Thrombosis 13, 720–728.CrossRefGoogle ScholarPubMed
Hixson, JE and Vernier, DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I Journal of Lipid Research 31, 545–554.CrossRefGoogle Scholar
Hozumi, YKawano, MSaito, T and Miyata, M (1998) Relation between apolipoprotein phenotype and the changes in lipids during tamoxifen treatment Endocrinology Journal 45, 255–259.Google ScholarPubMed
Karpe, FSteiner, GUffelman, K, Olivecrona, T and Hamsten, A (1994) Postprandial lipoproteins and progression of coronary atherosclerosis Atherosclerosis 106, 83–97.CrossRefGoogle ScholarPubMed
Kosykh, VANovikov, DKTrakht, IN, Podrez, EAVictorov, AV, Repin, VS and Smirnov, VN (1991) Effect of chylomicron remnants on cholesterol metabolism in cultured rabbit hepatocytes: very low density lipoprotein and bile acid production Lipids 26, 799–805.CrossRefGoogle ScholarPubMed
Kushwaha, RSHazzard, WRGagne, CChait, A and Albers, JJ (1977) Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogens Annals of Internal Medicine 87, 517–525.CrossRefGoogle Scholar
Lalazar, AWeisgraber, KHRall, SC, Giladj, HInnerarity, TLLevanon, AZ, Boyles, JKAmit, BGorecki, M, Mahley, RW and Vogel, T (1988) Site-specific mutagenesis of human apolipoprotein E Journal of Biological Chemistry 263, 3542–3545.CrossRefGoogle ScholarPubMed
Lohse, PMann, WAStein, EA and Brewer, HB (1991) Apolipoprotein E-4 Philadephia (Glu13→Lys, Arg145→Cys). Homozygoty for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia Journal of Biological Chemistry 266, 10479–10484.CrossRefGoogle Scholar
Mahley, RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240, 622–630.CrossRefGoogle ScholarPubMed
Mann, WAGregg, RESprecher, DL and Brewer, HB (1989) Apolipoprotein E-1 Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia Biochimica Biophysica Acta 1005, 239–244.CrossRefGoogle ScholarPubMed
Martz, WCezanne, S and Gross, W (1991) Phenotyping of apolipoprotein E by immunoblotting in immobilized pH gradients Electrophoresis 12, 59–63.CrossRefGoogle Scholar
Mekki, NChristofilis, MACharbonnier, MAtlan-Gepner, C, Defoort, CJuhel, C, Borel, PPortugal, H, Pauli, AMVialettes, B and Lairon, D (1999) Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women Journal of Clinical Endocrinology and Metabolism 84, 184–191.Google ScholarPubMed
Miller, DBHegele, RAWolfe, BM and Huff, MW (1995) Identification, molecular characterization and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia Journal of Clinical Endocrinology and Metabolism 80, 807–813.Google ScholarPubMed
Minnich, AWeisgraber, KHNewhouse, YDoug, LMFortin, LJ, Tremblay, M and Davignon, J (1995) Identification and characterization of a novel apolipoprotein E variant apolipoprotein E3 (Arg 136→His): association with mild dyslipidemia and double pre-beta very low density lipoproteins Journal of Lipid Research 36, 57–66.CrossRefGoogle Scholar
Moriyama, KSasaki, JTakada, G, Arakawa, FMatsunaga, A, Ito, Y and Arakawa, K (1996) Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg 224→Glu) in a hyperlipidemic patient with xanthomatosis Biochimica Biophysica Acta 1301, 185–190.CrossRefGoogle Scholar
Nilsson-Ehle, P and Schotz, MC (1976) A stable radioactive substrate emulsion for assay of lipoprotein lipase Journal of Lipid Research 17, 536–541.CrossRefGoogle ScholarPubMed
Okubo, MAoyama, YHarada, K, Fukawa, MToukada, T, Mokuno, HYamada, N and Murase, T (1998) A novel apolipoprotein E2 variant E2 Toranomon (Q 187 E) identified in a type III hyperlipoproteinemic patient with coronary atherosclerosis Atherosclerosis 140, 187–190.Google Scholar
Ordovas, JMLitwack-Klein, LWilson, PWFSchaefer, MM and Schaefer, EJ (1987) Apolipoprotein E isoforms phenotyping methodology and population frequency with identification of apo E1 and apo E5 isoforms Journal of Lipid Research 28, 371–380.CrossRefGoogle ScholarPubMed
Papamandjaris, AAMacDougall, DE and Jones, PJ (1998) Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications Life Sciences 62, 1203–1215.CrossRefGoogle ScholarPubMed
Parlier, GThomas, GBereziat, G, Fontaine, JL and Girardet, JP (1997) Relation of apolipoprotein E polymorphism to lipid metabolism in obese children Pediatric Research 41, 682–685.CrossRefGoogle ScholarPubMed
Patsch, JRMiesenbock, GHopferwieser, T, Muahlberger, V, Knapp, EKay Dunn, JGotto, AM and Patsch, W (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state Arteriosclerosis Thrombosis 12, 1336–1345.CrossRefGoogle ScholarPubMed
Pocovi, MCenarro, A Civeira F, Myers, RHCasao, EEsteban, M and Ordovas, JM (1996) Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg 136→Ser) variant in multigenerational pedigree studies Atherosclerosis 122, 33–46.CrossRefGoogle ScholarPubMed
Rall, SCWeisgraber, KHInnerarity, TL, Berot, TP and Mahley, RW (1983) Identification of a new structural variant of human apolipoprotein E, E2 (Lys 146-Gln) in a type III hyperlipoproteinemic subject with the E3/E2 phenotype Journal of Clinical Investigation 72, 1288–1297.CrossRefGoogle Scholar
Rall, SCWeisgraber, KH and Mahley, RW (1982) Human apolipoprotein E. The complete amino acid sequence Proceedings of National Academy of Science (USA) 79, 4696–4700.CrossRefGoogle Scholar
Rall, SCWeisgraber, KH and Mahley, RW (1982) Human apolipoprotein E. The complete amino acid sequence Journal of Biological Chemistry 257, 4171–4178.CrossRefGoogle ScholarPubMed
Reznik, YPousse, PHerrou, M, Morello, RMahoudeau, J, Drosdowsky, MA and Fradin, S (1996) Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism Metabolism 45, 63–71.CrossRefGoogle ScholarPubMed
Richard, Pde Zulueta, MPBeneler, IDe Gennes, JLCassaigne, A and Iron, A (1995) Identification of a new apoliprotein E variant (E2 Arg 142→Leu) in type III hyperlipidemia Atherosclerosis 112, 19–28.CrossRefGoogle Scholar
Rosseneu, M and Labeur, C (1995) Physiological significance of apolipoprotein mutants FASEB 9, 768–776.CrossRefGoogle ScholarPubMed
Sijbrands, EJWestendorp, RGHoffer, MJ, Frants, RRMeinders, AE, Souveriijn, JHGevers Leuven, JAVan der Laarse, AHavekes, LM and Smelt, AH (1996) Effect of lipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients Atherosclerosis 126, 197–205.CrossRefGoogle ScholarPubMed
Simons, LADwyer, TSimons, J, Bernstein, LMock, P, Poonia, NSBalasubramian, SBaron, D, Branson, JMorgan, J and Roy, P (1987) Chylomicrons and chylomicron remnants in coronary artery disease Atherosclerosis 65, 181–189.CrossRefGoogle ScholarPubMed
Srivasta, RASrivasta, NAverna, M, Lin, RCKorach, KS, Lubahn, DB and Schonfeld, G (1997) Estrogen up-regulates apolipoprotein E (ApoE) gene expressions by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway Journal of Biological Chemistry 272, 33360–33365.CrossRefGoogle Scholar
Tozuka, MYamauchi, KHidaka, H, Nakabayashi, TOkumara, N and Katsuyama, T (1997) Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma Annals Clinical Laboratory Science 27, 351–357.Google ScholarPubMed
Walden, CC and Hegele, RA (1994) Apoprotein E in hyperlipidemia Annals of Internal Medicine 120, 1026–1036.CrossRefGoogle ScholarPubMed
Walden, CCHuff, MWLeiter, LA, Connelly, PW and Hegele, RA (1994) Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping Journal of Clinical Endocrinology and Metabolism 78, 699–704.Google ScholarPubMed
Wardell, MRBrennan, SOJanus, ED, Fraser, R and Carrell, RW (1987) Apolipoprotein E2- Christchurch (136 Arg→Ser) Journal of Clinical Investigation 80, 483–490.CrossRefGoogle ScholarPubMed
Weintraub, GEisenberg, S and Breslow, JL (1987) Dietary fat clearance in normal subjects is regulated by genetic variations in apolipoprotein E Journal of Clinical Investigation 80, 1571–1577.CrossRefGoogle ScholarPubMed
Weisgraber, HRall, SCInnerarity, TLMahley, RWKuusi, T and Ehnholm, C (1984) A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1 Journal of Clinical Investigation 73, 1024–1033.CrossRefGoogle ScholarPubMed
Weisgraber, KHInnerarity, TL and Mahley, RW (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cystein–arginine interchange at a single site Journal of Biological Chemistry 257, 2518–2521.CrossRefGoogle Scholar
Wenham, PRMcDowell, IFW, Hodges, VMMcEnemy, J, O'Kane, MJDavies, RJHNicholls, DPTrimble, ER and Blundell, G (1993) Rare apolipoprotein E variant identified in a patient with type III hyperlipidemia Atherosclerosis 99, 261–271.CrossRefGoogle Scholar
Wilson, CWardell, MRWeisgraber, KH, Mahley, RW and Agard, DA (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E Science 252, 1817–1822.CrossRefGoogle ScholarPubMed
Zhao, SPVan den Maagdenberg, AMVroom, TF, Van't Hooft, FMGevers Leuven, JAHavekes, LM, Frants, RVan der Laarse, A and Smelt, AH (1994) Lipoprotein profiles in a family with 2 mutants of apolipoprotein E: possible association with hypertriglyceridemia but not with dysbetalipoproteinemia Clinical Science 86, 323–329.CrossRefGoogle Scholar
Zilversmit, DB (1979) Atherogenesis: a postprandial phenomenon Circulation 60, 473–485.CrossRefGoogle ScholarPubMed